{"id":511761,"date":"2021-07-12T08:33:31","date_gmt":"2021-07-12T12:33:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/"},"modified":"2021-07-12T08:33:31","modified_gmt":"2021-07-12T12:33:31","slug":"prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/","title":{"rendered":"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>GARDEN CITY, NY, July  12, 2021  (GLOBE NEWSWIRE) &#8212; <\/strong>ProPhase Labs, Inc. (Nasdaq: PRPH) (\u201cProPhase\u201d or the \u201cCompany\u201d), a diversified medical science and technology company, today announced that Chief Executive Officer Ted Karkus will present a corporate overview at the Access to Giving Virtual Investor Conference being held on July 13 &#8211; 15, 2021.<\/p>\n<p align=\"justify\">Mr. Karkus will deliver his corporate presentation on July 15 at 9:30am ET. Management will be available for one-on-one meetings to be held throughout the conference.<\/p>\n<p align=\"justify\">To receive additional information, request an invitation or to schedule a one-on-one meeting, please email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jvDdCP-15RSc9z0l9_RkDu-NexzjuBTpBHEs1aOqLJlp3C2q6nUDfE5RRsZerdbp4SOs_p113tvMfd2ay8jQrNqmhtIsR089I8Cs5n3UdYYQLIFJyJ5J8w-pt7axLgMG\" rel=\"nofollow noopener\" target=\"_blank\">angie.goertz@issuerdirect.<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0Nf1Gm-FjzTHE0Vo-nYDxt0cfLSP7CLJhBn6b9Fiz1O-w0xnkaograBaDvh60eW1KqE1Oer8B0BuGeSFEOf5Ww==\" rel=\"nofollow noopener\" target=\"_blank\">c<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yt1o0XSJ6qL1cn6JYwid-fc4QPWOnA5nn6H7JnGMCsWzKDbG4eCOhgy0Y2jb7iLWxKzfbhr0SeFLnpwfYQFbAQ==\" rel=\"nofollow noopener\" target=\"_blank\">om<\/a>.<\/p>\n<p align=\"justify\">Investors can register\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ey1JjC0I0AGWAR38gWz519SxfWrRrKeVPe18TEzIHgGOnCxYUHRkhlY8_wT2_6PzhBfPY6VZEKBuzHNM5CzQAsikOM_o11OHGLCwux5eeiD8_ZjuroLBEmP0i8rtP39Y\" rel=\"nofollow noopener\" target=\"_blank\">here.<\/a><\/p>\n<p align=\"justify\">\n        <strong>About\u00a0<\/strong><br \/>\n        <strong>ProPhase<\/strong><br \/>\n        <strong>\u00a0Labs<\/strong>\n      <\/p>\n<p align=\"justify\">ProPhase Labs, Inc. (Nasdaq: PRPH) is a diversified medical science and technology company. The Company\u2019s subsidiary, ProPhase Diagnostics, offers a broad array of clinical diagnostic insights and testing services at its CLIA certified laboratories. ProPhase Diagnostics serves patients with SARS-CoV-2 (COVID-19) through both saliva and nasal swab methods. Our methodology also has the capability to identify the possibility of mutations. Critical to COVID testing, results are provided in under 24 hours. ProPhase also offers PCR (polymerase chain reaction) testing for Influenzas A and B and RSV. ProPhase Diagnostics now offers antigen and antibody\/immunity tests in partnership with scientists to broaden its COVID-19 testing beyond RT-PCR testing. ProPhase Labs researches, develops, manufactures, distributes, markets, and sells OTC consumer healthcare products and dietary supplements, including dietary supplements under the TK Supplements<sup>\u00ae<\/sup>\u00a0brand. ProPhase actively pursues strategic investments and acquisition opportunities for other companies, technologies, and products. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S-ig6ZR8bgigNO_fWtZ6cBq2K6tdLPc_r6CDZO2dBJpnJ88aTo5XnTtIllLZ4QZ-2upOF43wDqCe-Z8dP0vKKSDOR8dtksEJ359s7xcUSg8=\" rel=\"nofollow noopener\" target=\"_blank\">www.ProPhaseLabs.com.<\/a><\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>CORE IR<br \/>Jules Abraham<br \/>917-885-7378<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q8Wf1l6oOlPioBzAf9xgsmyDat5neG-dI5P4qBFvBupU8trULx3gl3nUUw8Z-5IWzQy1FYTCbiuL4YXMsO0HQA==\" rel=\"nofollow noopener\" target=\"_blank\">julesa@coreir.com<\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/bede2a36-85ef-4586-8b17-97c838cfce10\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GARDEN CITY, NY, July 12, 2021 (GLOBE NEWSWIRE) &#8212; ProPhase Labs, Inc. (Nasdaq: PRPH) (\u201cProPhase\u201d or the \u201cCompany\u201d), a diversified medical science and technology company, today announced that Chief Executive Officer Ted Karkus will present a corporate overview at the Access to Giving Virtual Investor Conference being held on July 13 &#8211; 15, 2021. Mr. Karkus will deliver his corporate presentation on July 15 at 9:30am ET. Management will be available for one-on-one meetings to be held throughout the conference. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com. Investors can register\u00a0here. About\u00a0 ProPhase \u00a0Labs ProPhase Labs, Inc. (Nasdaq: PRPH) is a diversified medical science and technology company. The Company\u2019s subsidiary, ProPhase Diagnostics, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-511761","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GARDEN CITY, NY, July 12, 2021 (GLOBE NEWSWIRE) &#8212; ProPhase Labs, Inc. (Nasdaq: PRPH) (\u201cProPhase\u201d or the \u201cCompany\u201d), a diversified medical science and technology company, today announced that Chief Executive Officer Ted Karkus will present a corporate overview at the Access to Giving Virtual Investor Conference being held on July 13 &#8211; 15, 2021. Mr. Karkus will deliver his corporate presentation on July 15 at 9:30am ET. Management will be available for one-on-one meetings to be held throughout the conference. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com. Investors can register\u00a0here. About\u00a0 ProPhase \u00a0Labs ProPhase Labs, Inc. (Nasdaq: PRPH) is a diversified medical science and technology company. The Company\u2019s subsidiary, ProPhase Diagnostics, &hellip; Continue reading &quot;ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-12T12:33:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021\",\"datePublished\":\"2021-07-12T12:33:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/\"},\"wordCount\":276,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/\",\"name\":\"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==\",\"datePublished\":\"2021-07-12T12:33:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/","og_locale":"en_US","og_type":"article","og_title":"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021 - Market Newsdesk","og_description":"GARDEN CITY, NY, July 12, 2021 (GLOBE NEWSWIRE) &#8212; ProPhase Labs, Inc. (Nasdaq: PRPH) (\u201cProPhase\u201d or the \u201cCompany\u201d), a diversified medical science and technology company, today announced that Chief Executive Officer Ted Karkus will present a corporate overview at the Access to Giving Virtual Investor Conference being held on July 13 &#8211; 15, 2021. Mr. Karkus will deliver his corporate presentation on July 15 at 9:30am ET. Management will be available for one-on-one meetings to be held throughout the conference. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com. Investors can register\u00a0here. About\u00a0 ProPhase \u00a0Labs ProPhase Labs, Inc. (Nasdaq: PRPH) is a diversified medical science and technology company. The Company\u2019s subsidiary, ProPhase Diagnostics, &hellip; Continue reading \"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-12T12:33:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021","datePublished":"2021-07-12T12:33:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/"},"wordCount":276,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/","name":"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==","datePublished":"2021-07-12T12:33:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODQ5MSM0MjkxODUyIzUwMDA0ODEyOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-15-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=511761"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511761\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=511761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=511761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=511761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}